Boston Scientific Will Buy Penumbra In $14.5 Billion Medtech Deal
Investor's Business Daily • • business
Key Points:
- Investor’s Business Daily provides information solely for informational and educational purposes and does not offer investment advice or recommendations.
- The data is sourced from what are believed to be reliable sources, but accuracy, timeliness, and suitability are not guaranteed.
- Past investment performance does not predict future results, and authors may hold positions in the stocks they discuss.
- The company disclaims warranties regarding the advisability of specific securities or strategies, and information is subject to change without notice.
- Real-time price data comes from Nasdaq Last Sale, with ownership and estimate data provided by LSEG and FactSet, respectively; Investor’s Business Daily and related marks are registered trademarks.
